托克二醇异型:它们在癌症治疗中的作用背后的分子机制以及它们在临床试验中的实施
Maria Younes1, Ghady Loubnane1, Christopher Sleiman1
1Department of Natural Sciences, Lebanese American University, Byblos, Lebanon.
Journal of integrative medicine
|February 9, 2024
概括
托克醇是一种维生素E的形式,在抑制各种类型的癌症生长方面显示出显著的前景. 进一步的研究和临床试验正在探索它们在癌症预防和治疗方面的潜力.
科学领域:
- 营养生物化学 营养生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于人口老龄化和西方生活方式因素,全球癌症发病率正在上升.
- 在棕油和大米等自然来源中发现的托克醇具有促进健康的特性.
- 这些化合物已证明对许多癌症类型有抑制作用.
研究的目的:
- 在癌症中审查托科特里昂醇异型的分子机制.
- 评估维生素E类别对癌症特征的治疗潜力.
- 评估用于癌症化学预防的托科特里昂醇的临床证据.
主要方法:
- 在MEDLINE/PubMed和Scopus数据库中进行文献搜索.
- 对维生素E衍生物抗癌作用的体外和体内研究的分析.
- 对临床试验的综述 调查托科特里昂醇在癌症治疗中的作用.
主要成果:
- 托科特里昂醇抑制了扩散,血管生成和转移,同时在各种癌症模型中促进了亡.
- 临床前数据强烈支持托科醇的抗癌作用.
- 目前正在进行临床试验,以确定它们在癌症治疗中的作用.
结论:
- 托科特里昂醇具有作为抗癌剂的显著潜力.
- 它们的安全性和有效性需要进一步研究以获得临床应用.
- 在未来的癌症化疗方案中,托克醇可能会变得有价值.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
